Because no one has access to the data in the first part of the...

Because no one has access to the data in the first part of the Phase III trial, I doubt whether a USA deal will eventuate anytime soon. Would a US company jump in based on a generic recommendation to proceed to the next trial stage? Would they not want to see some hard data?

From what Nina has said about the respective regulatory authorities, I think a China deal is more likely to happen first but who knows how long that would take to organise.

The final readout will be met with great anticipation, but with a very long wait until the final results, I expect the share price to sit quietly for quite a while.

Just my thoughts. As always, I won't turn down unexpected great news.